Ben Golland


After gaining a BSc in Biochemsitry from the University of Birmingham and spending a year at GSK, I decided to move into engineering. I feel the application of science is both important and enjoyable, which is reflected in the antibody engineering work I conducted at GSK and my final year project analysing the current FDA approved drug library for novel anti-tuberculosis drugs. The Institute of Medical and Biological Engineering (iMBE) and the University of Leeds in general has a strong interest in translation which aligns with my own focus to push science from benchside to bedside. 

Research interests

  • Spinal cord injury repair
  • Nerve regeneration
  • Electrospinning of polymers
  • Self-assembling peptides
  • Protection of knowledge
  • Route to commercialisation


  • Current: PhD in Tissue Engineering & Regenerative Medicine
  • BSc Biochemistry with Year in Industry

Research groups and institutes

  • Institute of Medical and Biological Engineering